US Stock MarketDetailed Quotes

ELYM Eliem Therapeutics

Watchlist
  • 8.110
  • +0.110+1.38%
Trading Sep 13 12:11 ET
543.86MMarket Cap-3653P/E (TTM)

Eliem Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
91.63%-667K
88.01%-1.82M
44.88%-20.6M
88.79%-947K
183.59%3.49M
42.97%-7.97M
-40.80%-15.18M
-3.60%-37.37M
-7.17%-8.45M
67.80%-4.18M
Net income from continuing operations
-951.51%-54.89M
92.39%-1.7M
22.38%-35.12M
53.09%-3.64M
59.02%-3.97M
64.24%-5.22M
-68.81%-22.29M
4.71%-45.24M
26.39%-7.76M
-0.70%-9.68M
Operating gains losses
95.24%-19K
112.12%28K
-174.51%-304K
118.21%330K
-100.40%-4K
-137.96%-399K
-230.51%-231K
266.53%408K
---1.81M
1,355.70%992K
Other non cash items
46,944.55%51.75M
-27.87%88K
-8.58%405K
-23.68%87K
-23.21%86K
0.92%110K
12.96%122K
-96.22%443K
--114K
--112K
Change In working capital
174.10%1.98M
73.96%-640K
1,692.38%3.76M
393.60%1.42M
177.81%7.47M
-11.24%-2.67M
-705.42%-2.46M
105.03%210K
-139.67%-484K
158.58%2.69M
-Change in prepaid assets
373.05%2.21M
764.00%216K
679.89%7.37M
663.50%1.54M
1,648.01%6.61M
-3.19%-809K
-98.97%25K
109.21%945K
-132.50%-274K
94.15%-427K
-Change in payables and accrued expense
92.12%-104K
46.10%-725K
-1,346.93%-3.3M
98.47%-2K
49.24%-633K
-278.97%-1.32M
-425.67%-1.35M
-106.48%-228K
-129.77%-131K
-905.65%-1.25M
-Change in other current assets
--0
101.34%15K
291.67%115K
-91.67%1K
-63.42%1.64M
81.52%-409K
52.34%-1.12M
-102.34%-60K
117.14%12K
58.90%4.49M
-Change in other current liabilities
7.41%-125K
-668.42%-146K
5.59%-422K
-34.07%-122K
-16.80%-146K
4.93%-135K
78.65%-19K
-6,485.71%-447K
-1,400.00%-91K
---125K
Cash from discontinued investing activities
Operating cash flow
91.63%-667K
88.01%-1.82M
44.88%-20.6M
88.79%-947K
183.59%3.49M
42.97%-7.97M
-40.80%-15.18M
-3.60%-37.37M
-7.17%-8.45M
67.80%-4.18M
Investing cash flow
Cash flow from continuing investing activities
-502.44%-9.65M
137.21%13.75M
100.29%68.98M
157.37%36.75M
229.50%28.04M
-110.21%-1.6M
243.67%5.8M
129.96%34.44M
277.34%14.28M
107.96%8.51M
Net investment purchase and sale
--0
137.21%13.75M
100.29%68.98M
157.37%36.75M
229.50%28.04M
-110.21%-1.6M
243.67%5.8M
129.96%34.44M
277.34%14.28M
107.96%8.51M
Cash from discontinued investing activities
Investing cash flow
-502.44%-9.65M
137.21%13.75M
100.29%68.98M
157.37%36.75M
229.50%28.04M
-110.21%-1.6M
243.67%5.8M
129.96%34.44M
277.34%14.28M
107.96%8.51M
Financing cash flow
Cash flow from continuing financing activities
534,908.33%128.4M
1,400.00%15K
841K
288K
528K
24K
1K
0
0
0
Proceeds from stock option exercised by employees
35,950.00%8.65M
1,400.00%15K
--841K
--288K
--528K
--24K
--1K
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
534,908.33%128.4M
1,400.00%15K
--841K
--288K
--528K
--24K
--1K
--0
--0
--0
Net cash flow
Beginning cash position
204.99%105.03M
113.63%93.11M
-7.11%43.59M
59.56%57.35M
-22.42%25.29M
7.85%34.44M
-7.11%43.59M
129.03%46.92M
-42.78%35.94M
-67.23%32.6M
Current changes in cash
1,337.58%118.09M
227.38%11.95M
1,780.54%49.22M
519.13%36.09M
639.62%32.06M
-654.12%-9.54M
36.69%-9.38M
-111.18%-2.93M
136.67%5.83M
111.80%4.33M
Effect of exchange rate changes
-95.24%19K
-112.12%-28K
174.51%304K
-118.21%-330K
100.40%4K
137.96%399K
230.51%231K
-266.53%-408K
--1.81M
-1,355.70%-992K
End cash Position
782.19%223.14M
204.99%105.03M
113.63%93.11M
113.63%93.11M
59.56%57.35M
-22.42%25.29M
7.85%34.44M
-7.11%43.59M
-7.11%43.59M
-42.78%35.94M
Free cash flow
91.63%-667K
88.01%-1.82M
44.88%-20.6M
88.79%-947K
183.59%3.49M
42.97%-7.97M
-40.80%-15.18M
-3.60%-37.37M
-7.17%-8.45M
67.80%-4.18M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 91.63%-667K88.01%-1.82M44.88%-20.6M88.79%-947K183.59%3.49M42.97%-7.97M-40.80%-15.18M-3.60%-37.37M-7.17%-8.45M67.80%-4.18M
Net income from continuing operations -951.51%-54.89M92.39%-1.7M22.38%-35.12M53.09%-3.64M59.02%-3.97M64.24%-5.22M-68.81%-22.29M4.71%-45.24M26.39%-7.76M-0.70%-9.68M
Operating gains losses 95.24%-19K112.12%28K-174.51%-304K118.21%330K-100.40%-4K-137.96%-399K-230.51%-231K266.53%408K---1.81M1,355.70%992K
Other non cash items 46,944.55%51.75M-27.87%88K-8.58%405K-23.68%87K-23.21%86K0.92%110K12.96%122K-96.22%443K--114K--112K
Change In working capital 174.10%1.98M73.96%-640K1,692.38%3.76M393.60%1.42M177.81%7.47M-11.24%-2.67M-705.42%-2.46M105.03%210K-139.67%-484K158.58%2.69M
-Change in prepaid assets 373.05%2.21M764.00%216K679.89%7.37M663.50%1.54M1,648.01%6.61M-3.19%-809K-98.97%25K109.21%945K-132.50%-274K94.15%-427K
-Change in payables and accrued expense 92.12%-104K46.10%-725K-1,346.93%-3.3M98.47%-2K49.24%-633K-278.97%-1.32M-425.67%-1.35M-106.48%-228K-129.77%-131K-905.65%-1.25M
-Change in other current assets --0101.34%15K291.67%115K-91.67%1K-63.42%1.64M81.52%-409K52.34%-1.12M-102.34%-60K117.14%12K58.90%4.49M
-Change in other current liabilities 7.41%-125K-668.42%-146K5.59%-422K-34.07%-122K-16.80%-146K4.93%-135K78.65%-19K-6,485.71%-447K-1,400.00%-91K---125K
Cash from discontinued investing activities
Operating cash flow 91.63%-667K88.01%-1.82M44.88%-20.6M88.79%-947K183.59%3.49M42.97%-7.97M-40.80%-15.18M-3.60%-37.37M-7.17%-8.45M67.80%-4.18M
Investing cash flow
Cash flow from continuing investing activities -502.44%-9.65M137.21%13.75M100.29%68.98M157.37%36.75M229.50%28.04M-110.21%-1.6M243.67%5.8M129.96%34.44M277.34%14.28M107.96%8.51M
Net investment purchase and sale --0137.21%13.75M100.29%68.98M157.37%36.75M229.50%28.04M-110.21%-1.6M243.67%5.8M129.96%34.44M277.34%14.28M107.96%8.51M
Cash from discontinued investing activities
Investing cash flow -502.44%-9.65M137.21%13.75M100.29%68.98M157.37%36.75M229.50%28.04M-110.21%-1.6M243.67%5.8M129.96%34.44M277.34%14.28M107.96%8.51M
Financing cash flow
Cash flow from continuing financing activities 534,908.33%128.4M1,400.00%15K841K288K528K24K1K000
Proceeds from stock option exercised by employees 35,950.00%8.65M1,400.00%15K--841K--288K--528K--24K--1K--0--0--0
Cash from discontinued financing activities
Financing cash flow 534,908.33%128.4M1,400.00%15K--841K--288K--528K--24K--1K--0--0--0
Net cash flow
Beginning cash position 204.99%105.03M113.63%93.11M-7.11%43.59M59.56%57.35M-22.42%25.29M7.85%34.44M-7.11%43.59M129.03%46.92M-42.78%35.94M-67.23%32.6M
Current changes in cash 1,337.58%118.09M227.38%11.95M1,780.54%49.22M519.13%36.09M639.62%32.06M-654.12%-9.54M36.69%-9.38M-111.18%-2.93M136.67%5.83M111.80%4.33M
Effect of exchange rate changes -95.24%19K-112.12%-28K174.51%304K-118.21%-330K100.40%4K137.96%399K230.51%231K-266.53%-408K--1.81M-1,355.70%-992K
End cash Position 782.19%223.14M204.99%105.03M113.63%93.11M113.63%93.11M59.56%57.35M-22.42%25.29M7.85%34.44M-7.11%43.59M-7.11%43.59M-42.78%35.94M
Free cash flow 91.63%-667K88.01%-1.82M44.88%-20.6M88.79%-947K183.59%3.49M42.97%-7.97M-40.80%-15.18M-3.60%-37.37M-7.17%-8.45M67.80%-4.18M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data